Literature DB >> 19036916

Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.

Sylvie Deuffic-Burban1, Philippe Mathurin, Alain-Jacques Valleron.   

Abstract

Two national HCV projections have been published in France which assumed that a part of observed hepatocellular carcinoma (HCC) deaths is a consequence of HCV epidemic. They applied the back-calculation method, in combination with a Markov model, to reconstruct the past history of HCV infection and then to predict HCV-related mortality. A preliminary model was first developed in the absence of effective therapy. It allowed testing many assumptions to model HCV natural history that were compatible with observed incidence of HCV-related HCC deaths. This model was then updated to take into account the availability of treatment and more recent epidemiological data. These two models are described in detail and results are discussed with a view to addressing the models' limitations. The models offered a useful tool to assess public health policy scenarios in planning healthcare responses to the HCV epidemic.

Entities:  

Mesh:

Year:  2008        PMID: 19036916     DOI: 10.1177/0962280208094697

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  4 in total

Review 1.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

2.  Estimating the prevalence of hepatitis C infection in New York City using surveillance data.

Authors:  S Balter; J H Stark; J Kennedy; K Bornschlegel; K Konty
Journal:  Epidemiol Infect       Date:  2013-05-09       Impact factor: 2.451

3.  Estimated prevalence of Hepatitis C Virus infection in Canada, 2011.

Authors:  M Trubnikov; P Yan; C Archibald
Journal:  Can Commun Dis Rep       Date:  2014-12-18

4.  The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.

Authors:  Jeffrey Vietri; Girish Prajapati; Antoine C El Khoury
Journal:  BMC Gastroenterol       Date:  2013-01-17       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.